This article explains exactly why GLP-1 medications can trigger hair loss, who is most at risk, what the current medical literature says, and, most importantly, the full spectrum of treatment options available today, from topical and oral medications to PRP, Exosome Hair Therapy, and FUE Hair Transplant
For these reasons, I wanted to explore what GLP-1s can mean for womens health, starting with their effect on body composition
Your goals should be maintaining metabolic health rather than just stretching the medication
Over the next few weeks, Im going to be doing a 3-part series, examining GLP-1 receptor agonists
Future research priorities include: - Safety in Diverse Populations: Large-scale trials are needed to establish the long-term safety and efficacy of dual receptor agonists in special populations, including patients with type 1 diabetes and pregnant women
Indeed, data from STEP-HFpEF and STEP-HFpEF DM trials have shown a significant reduction in inflammatory markers such as CRP with semaglutide compared with placebo 45,46